AU2001250470A1 - Novel antibodies specifically identifying inactive psa, and uses thereof - Google Patents

Novel antibodies specifically identifying inactive psa, and uses thereof

Info

Publication number
AU2001250470A1
AU2001250470A1 AU2001250470A AU5047001A AU2001250470A1 AU 2001250470 A1 AU2001250470 A1 AU 2001250470A1 AU 2001250470 A AU2001250470 A AU 2001250470A AU 5047001 A AU5047001 A AU 5047001A AU 2001250470 A1 AU2001250470 A1 AU 2001250470A1
Authority
AU
Australia
Prior art keywords
antibody
antibodies specifically
novel antibodies
specifically identifying
zymogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001250470A
Other languages
English (en)
Inventor
Jean-Philippe Charrier
Colette Jolivet-Reynaud
Sandrine Michel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Publication of AU2001250470A1 publication Critical patent/AU2001250470A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2001250470A 2000-04-10 2001-04-10 Novel antibodies specifically identifying inactive psa, and uses thereof Abandoned AU2001250470A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0004591A FR2807438B1 (fr) 2000-04-10 2000-04-10 Nouveaux anticorps reconnaissant specifiquement le psa libre inactif, et leurs applications
FR0004591 2000-04-10
PCT/FR2001/001094 WO2001077180A1 (fr) 2000-04-10 2001-04-10 Anticorps reconnaissant specifiquement le psa inactif, et leurs applications

Publications (1)

Publication Number Publication Date
AU2001250470A1 true AU2001250470A1 (en) 2001-10-23

Family

ID=8849094

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001250470A Abandoned AU2001250470A1 (en) 2000-04-10 2001-04-10 Novel antibodies specifically identifying inactive psa, and uses thereof

Country Status (10)

Country Link
US (2) US20030153017A1 (de)
EP (1) EP1272525B1 (de)
AT (1) ATE336513T1 (de)
AU (1) AU2001250470A1 (de)
CA (1) CA2405637A1 (de)
DE (1) DE60122306T2 (de)
ES (1) ES2269376T3 (de)
FR (1) FR2807438B1 (de)
PT (1) PT1272525E (de)
WO (1) WO2001077180A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325483D0 (en) * 2003-10-31 2003-12-03 Plasmacute As Assay
US20070254317A1 (en) * 2004-03-03 2007-11-01 Biomerieux Method for Detecting the Activatable Free Form of Psa and the Use Thereof for Diagnosing Benign Pathologies of the Prostate and Adenocarcinoma of the Prostate
DE102007028659A1 (de) * 2007-06-21 2008-12-24 Siemens Ag Diagnosesubstanz und Verfahren zur Diagnose von Prostataerkrankungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
EP0635575A1 (de) * 1993-07-22 1995-01-25 Wallac Oy Monoklonale Antikörper gegen Epitope in freiem uber nicht in Alpha-1-antichymotrypsin komplexiertem Prostata spezifisches Antigen
CA2286090C (en) * 1997-04-30 2013-01-08 Hybritech Incorporated Forms of prostate specific antigen and methods for their detection
US5994085A (en) * 1997-08-26 1999-11-30 Cantor; Thomas L. Methods and devices for detecting non-complexed prostate specific antigen
FR2780791B1 (fr) * 1998-07-03 2000-09-01 Bio Merieux Methode de depistage ou de diagnostic d'un adenocarcinome ou d'une pathologie benigne de la prostate et procede de mise en oeuvre
US6482599B1 (en) * 1999-04-30 2002-11-19 Hybritech Incorporated Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such

Also Published As

Publication number Publication date
US20070020710A1 (en) 2007-01-25
ES2269376T3 (es) 2007-04-01
EP1272525A1 (de) 2003-01-08
DE60122306T2 (de) 2007-08-30
CA2405637A1 (fr) 2001-10-18
FR2807438A1 (fr) 2001-10-12
WO2001077180A1 (fr) 2001-10-18
PT1272525E (pt) 2006-12-29
EP1272525B1 (de) 2006-08-16
ATE336513T1 (de) 2006-09-15
DE60122306D1 (de) 2006-09-28
FR2807438B1 (fr) 2004-09-17
US20030153017A1 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
GB2374415B (en) Human antibodies as detection reagents
HK1099360A1 (en) Assay
AU2002304640A1 (en) Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
MXPA05005288A (es) Inmunoanalisis no competitivo para analitos pequenos.
ATE228247T1 (de) Testreagentien und testvorrichtungen
SE9502196L (sv) Immunanalys och testkit med två reagens som kan tvärbindas om de adsorberats till analyten
ATE410684T1 (de) Molekular-modifikations-assays
HK1080142A1 (en) Sensitive immunochromatographic assay
CA2480833A1 (en) Sensitive immunochromatographic assay
ATE274699T1 (de) Analytassay-vorrichtung mit vorabsorbieren-zone
ATE179799T1 (de) Vorrichtung zur analyse von haptenen und ihre verwendung
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
WO2005019831A3 (en) Methods for reducing complexity of a sample using small epitope antibodies
DE59712595D1 (de) Homogene Nachweisverfahren zur Bestimmung von Subpopulationen eines Analyten
DE60235011D1 (de) Assays für den präimplantationsfaktor und präimplantationsfaktorpeptide
RU2008130888A (ru) Мас-2вр как маркер для диагностики рака желудка
WO2004081025A3 (en) Differential megaplex immunoassay
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
AU2001250470A1 (en) Novel antibodies specifically identifying inactive psa, and uses thereof
AU2003248619A1 (en) Method for the elimination of interferences in immunochromatographic assays
CA2434694A1 (en) Detection and quantification of cripto-1
WO2006060188A3 (en) Anti-tenascin monoclonal antibody immunoassays and diagnostic kits
YU15401A (sh) Antitela visokog afiniteta
GB9823397D0 (en) Assays for thyroid autoantibodies
WO2006138694A3 (en) Rabbit monoclonal antibody against id1 protein